1 recruiting. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
Follow haplo-cord HSCT: new trials by email Literature Review of haplo-cord HSCT trials Research Report on haplo-cord HSCT
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Haplo-Cord HSCT for AML/MDS haplo-cord HSCT, Fludarabine, Cytarabine, Busulfan, Antithymocyte Globulin (ATG), Melphalan, Cyclophosphamide (CTX) - MDS (Myelodysplastic Syndrome), AML (Acute Myeloid Leukemia) | Not applicable | Recruiting | Fujian Medical University Union Hospital | 82 | 2025-10-20 | 2026-06-10 |
Anemia, Refractory, with Excess of Blasts (1) · Leukemia, Myeloid, Acute (1) · Myelodysplastic Syndromes (1)
Fujian Medical University Union Hospital (1)
China (1)
PMID 18997171, PMID 25891003, PMID 26450984, PMID 26551633, PMID 27602666, PMID 28436973, PMID 28665419, PMID 29860482, PMID 30372796, PMID 31270102, PMID 31431695, PMID 31477550, PMID 31739455, PMID 32247396, PMID 32518291, PMID 33832208, PMID 34455741, PMID 34804017